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ABSTRACT: This work is focused on the rational structural
design of two isostructural Cu(II) nano-coordination polymers
(NCPs) with uracil-1-acetic acid (UAcOH) (CP1n) and 5-
fluorouracil-1-acetic acid (CP2n). Suitable single crystals for X-ray
diffraction studies of CP1 and CP2 were prepared under
hydrothermal conditions, enabling their structural determination
as 1D-CP ladder-like polymeric structures. The control of the
synthetic parameters allows their processability into water colloids
based on nanoplates (CP1n and CP2n). These NCPs are stable in
water at physiological pHs for long periods. However, interestingly,
CP1n is chemically altered in culture media. These trans-
formations provoke the partial release of its building blocks and
the formation of new species, such as [Cu(UAcO)2(H2O)4]·2H2O (Cu(II)-complex), and species corresponding to the partial
reduction of the Cu(II) centers. The cytotoxic studies of CP1n versus human pancreatic adenocarcinoma and human uveal
melanoma cells show that CP1n produces a decrease in the cell viability, while their UAcOH and Cu(II)-complex are not cytotoxic
under similar conditions. The copper reduction species detected in the hydrolysis of CP1n are closely related to the formation of the
reactive oxygen species (ROS) detected in the cytotoxic studies. These results prompted us to prepare CP2n that was designed to
improve the cytotoxicity by the substitution of UAcO by 5-FUAcO, taking into account the anticancer activity of the 5-fluorouracil
moiety. The new CP2n has a similar behavior to CP1n both in water and in biological media. However, its subtle structural
differences are vital in improving its cytotoxic activity. Indeed, the release during the hydrolysis of species containing the 5-
fluorouracil moiety provokes a remarkable increase in cellular toxicity and a significant increase in ROS species formation.
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■ INTRODUCTION
Coordination polymers (CPs) are based on the organized
assembly of metal entities with organic and inorganic ligands
giving rise to one-, two-, or three-dimensional architectures.1−3
The large variety of the constituents allows the production of a
huge structural variety, with almost a la carte physico-chemical
properties,4,5 thanks to the combination of metal centers and
ligands.6−9 A relatively common feature of most of the CPs is
that they are quite insoluble in the reaction media, offering the
possibility to form nanostructures in a one-pot bottom-up
process8,10,11 upon adjustment of the experimental conditions
(i.e., temperature, concentration, and/or solvents).12 The
structural tunability of those nanostructures would enable the
synthesis of nano-coordination polymers (NCPs) with differ-
ent chemical and physical properties.13,14 Their nanometric
size and an appropriate structural design enable NCPs to be
useful as nanocarriers in biological processes.15
Besides, their coordination bonds are relatively labile. They
can undergo exchange reactions with other ligands present in
the medium as well as partial or complete solvolysis
(hydrolysis).16
Understanding these chemical transformations can be crucial
to take advantage of the use of CPs as pharmaceutical
precursors. Indeed, it has been reported that the chemical
response of some CPs enables them to be used to deliver
molecules of biological interest,17 or even their chemical
transformation and reorganization can in situ produce
interesting new drugs.13,14,18−21
On the other hand, copper(II) ions can promote some
selective cell toxicity, allowing the manufacture of coordination
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complexes that can also be used as anticancer or antibacterial
agents.17,21 The reports related to this topic are diverse,
including those dealing with copper(II) coordination com-
plexes with different cytotoxicity potentials, from non-toxic to
highly toxic.22−25 However, these studies clearly show that the
cytotoxicity of copper(II) complexes mainly depends on the
type of ligands bound to the metal center and not in the
presence of the copper(II) ion.26 It also seems that the
cytotoxic activity and their interaction with the DNA are
usually more significant in coordination complexes than in the
precursor copper salts (i.e., hexa-aqua copper(II) com-
plex).27,28 Previous studies have stressed that the mechanisms
involved in the copper(II) cytotoxicity are not easy to unravel
and the results depend on many experimental factors such as
pH, size, and biological media in addition to the solubility of
the Cu(II) complexes.29
It has to be noted that only a few studies are focused on the
analysis of CPs in biological media. The results are beginning
to show some indications about their possible behaviors and
their relationship with their cytotoxic activity.15,30,31 In this
regard, a recent study has shown that the cytotoxic activity of
16 different nano-MOFs primarily depends on their solubility
in biological media and on the amount of metal ion [Zr(IV),
Fe(III), Zn(II), Mn(II), Co(II), Ni(II), Cu(II), and Mg(II)]
released. The most toxic are those that present a more
significant amount of metal ion release.30 A disadvantage of the
nano-MOFs studied from the biological point of view is that
they are generally obtained or dispersed in organic solvents,
therefore limiting the studies in biological conditions.30,32,33
They also reported that the nano-MOFs could undergo
structural rearrangements and chemical reactions, producing
new inorganic species in biological media.30
Therefore, the synthesis of new NCPs based on copper(II)
with selected biological ligands such as uracil derivatives such
as 5-fluorouracil (5-FU), one of the most effective antineo-
plastic agents, or related derivatives, could produce new
materials with synergistic effects and interesting therapeutic
properties. Moreover, its study in biological media is an
exciting challenge from the pharmacological point of view.
Since previous studies still show a significant number of
doubts and controversies, in this work, we try to deepen the
design of new CPs considering their behavior in biological
media. This work attempts to serve as a proof of concept in
using NCPs as active drugs.
This study shows the one-step synthesis under hydrothermal
conditions and the characterization of a new 1D-copper(II)−
uracil-1-acetate CP. The CP has been nanoprocessed via
bottom-up due to its high insolubility in water at room
temperature. The obtained colloidal suspension of nanoplates
becomes hydrolyzed in physiological serums, releasing some of
its constituents into the environment and promoting a
cytotoxic response. Based on this behavior, a modification
was performed by synthesizing a new isostructural Cu(II) CP
where 5-fluorouracil-1-acetate replaces uracil-1-acetate
(Scheme 1). The new NCP is also hydrolyzed in the biological
media, leading to a chemical reorganization of the CP and a
partial release of the ligands. Furthermore, their in-vitro
cytotoxicity in melanoma and pancreatic cancer cells has been
studied, compared, and related with their chemical behavior
and the selected building blocks. Indeed, the above-mentioned
hydrolysis taking place in the biological media agrees with the
higher cytotoxicity, and the greater generation of reactive
oxygen species (ROS) is observed when 5-fluorouracil-1-acetic
acid (5-FUAcOH) is selected as the ligand.
■ RESULTS AND DISCUSSION
Synthesis and Structure. Good-quality single crystals of
CP1 and CP2 were prepared under hydrothermal conditions
(120 °C for 3 and 2 days of reaction time, respectively),
enabling their structural determination.
CP1 consists of a 1D-CP ladder-like polymeric structure
with the formula [Cu2(UAcO)4(4,4′-bipy)2]n·3H2O (Figure
1). The copper(II) metal centers are bridged by double μ-
UAcOH-κO:κO [3.4179(13) Å] and μ-4,4′-bipy-κN:κN′
[11.1216(17) Å] ligands to define the side rail and the rung
of the ladder chain, respectively.
The copper(II) metal centers are bridged simultaneously by
μ-4,4′’-bipy-κN:κN′’ [11.1216(17) Å] and double μ-UAcOH-
κO:κO [3.4179(13) Å] ligands in such a way that they define
what it would be the side rail and rung of a ladder like chain,
respectively. The coordination geometry around the metal
center includes the terminally coordinated uracil-1-acetate and
the bridging 4,4′-bipy ligands to adopt an elongated N2O3
square pyramidal geometry. The basal plane is occupied by two
trans arranged nitrogen atoms coming from the 4,4′-bipy
ligands, an oxygen atom belonging to the carboxylate group of
the terminally coordinated UAcO ligand, and a bridging UAcO
ligand. The apical position is occupied by an oxygen atom from
the UAcO bridging ligand and shows a significantly longer
Cu−O distance. The acetate ligand acquires an asymmetric μ-
oxo coordination mode where the same oxygen atom is located
in the basal plane of a metal center [1.961(6) Å] and in the
apical position of another copper(II) ion [2.403(6) Å]. The
existence of a double acetate bridge connecting the copper(II)
centers (the rung of the ladder chain) gives rise to a Cu2O2
planar square with Cu−O−Cu and O−Cu−O angles of
99.7(2) and 80.3(2)°, respectively. The two coordinated
carboxylate groups (from uracil-1-acetate ligands) are nearly
coplanar to the Cu2O2 core (3.23 and 1.59°, respectively). The
4,4′-bipy ligands are perpendicularly arranged with respect to
this core (89.55°). Unsurprisingly, the uracil substituent is
almost perpendicular to the same dinuclear core (85.16°) and
nearly parallel to the 4,4′-bipy ligand (8.14°).
The uracil-1-acetate ligands coordinate the metal center
using only one of their carboxylate oxygen atoms, leaving the
rest of uracil available to stabilize the overall structure by
means of supramolecular interactions. Nevertheless, in spite of
the expected π-stacking interactions or direct complementary
hydrogen bonding between the nucleobases, they interact
favorably with the crystallization water molecules, and only C−
Scheme 1. Synthesis of [Cu2(UAcO)4(4,4′-bipy)2]n·3H2O
(CP1n) and [Cu2(5-FUAcO)4(4,4′-bipy)2]n·4H2O (CP2n)
as a Water Colloid
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H···O hydrogen bond interactions are observed between the
nucleobases. The latter interactions provide supramolecular
sheets that propagate in the (001) plane. One of the
crystallization water molecules establishes an O···H−Ow−
H···O double hydrogen bond with the two non-coordinated
oxygen atoms of the two carboxylate groups coordinated to the
metal center that strengthens their monodentate coordination
mode. The remaining two crystallographically independent
water molecules show additional Ow−H···Ow, Ow−H···O,
and N3−H···Ow hydrogen bonds that give the final overall
cohesiveness to the crystal structure.
The presence of two coordinated uracil-1-acetate ligands
implies a greater capability to establish π−π stacking
interactions and hydrogen bonds in the supramolecular
network. In fact, every ladder-like polymeric chain interacts
with four surrounding chains, two of them employing
hydrogen-bonding interactions and the other two through
π−π stacking interactions involving the uracil residues. The
hydrogen-bonding interaction can hold together the polymeric
chains in 2D supramolecular chains. Most of these hydrogen-
bonding interactions involve the non-coordinated oxygen
atoms of the carboxylate groups as the acceptor and the uracil
residue N3−H and bipyridine C−H groups, but a direct C−
H···O interaction is also found between the uracil residues
belonging to adjacent chains. The π−π stacking interactions
between the terminal UAcO uracil residues held together the
supramolecular sheets to generate the final 3D supramolecular
architecture. On the other hand, the relatively irregular shape
of the chains implies the presence of isolated voids within the
crystal structure that comprise 19.3% of the total volume.
However, as far as the direct supramolecular interactions
between the polymeric chains saturate almost all the hydrogen
bond donor and acceptor positions, the water molecules
located in these voids are only loosely attached to the
polymeric entities to provide a well-defined hydrogen-bonding
scheme. The disorder of these water molecules is so high that
their contribution was removed using the squeeze procedure as
implemented in PLATON.34
CP2, obtained using the same synthetic route but replacing
uracil-1-acetate with the 5-fluorouracil-1-acetate, presents a
very similar 1D ladder-like metal−organic molecular structure
(Figure 2). Again, the μ-4,4′-bipy-κN:κN′ [11.1216(17) Å]
and double μ-FUAcO-κO:κO [3.4179(13) Å] ligands define
the side rail and the rung of the ladder chain, respectively, and
the metal coordination sphere includes a terminally coordi-
nated 5-fluorouracil-1-acetate-κO ligand to give an elongated
N2O3 square pyramidal coordination geometry. The apical
position showing a significantly longer coordination bond
distance (2.40 vs 1.94−2.01 Å) is occupied by the oxygen atom
of the bridging 5-fluorouracil-1-acetate ligand. The Cu2O2
planar square that defines the rung of the ladder presents
Cu−O−Cu and O−Cu−O angles of 101.32(14) and
78.64(14)°, respectively. The 4,4′-bpy ligands are perpendic-
ular to this core (88.90°), and the uracil residues are almost
perpendicularly organized concerning the same dimeric core
(88.90 and 89.15°) and practically parallel with respect to the
4,4′-bipy ligand (1.32 and 9.37°).
As it can be seen, the molecular features of CP1 and CP2
are almost identical. Still, the 5-fluorouracil residues, not
involved in the coordination with the metal center, adopt
slightly different supramolecular interactions connecting the
ladder-like chains. In fact, fluorouracil residues are more
efficient in establishing the expected complementary hydrogen
bonds between the terminally coordinated 5-fluorouracil-
acetate ligands (double N13−H···O14 H-bonds; D···A:
2.867(7) Å and D−H···A: 168.4°), connecting each ladder-
like chain with two adjacent ones. Simultaneously, the bridging
5-fluorouracil-acetate ligands reinforce this supramolecular
interaction by establishing π−π interactions (9.3° between
the planar rings and closest distances: 3.12−3.35 Å) between
their 5-FU residue and the same residue belonging to the
bridging 5-fluorouracil-acetate ligand of the adjacent chain,
which is, as previously stated, also involved in the
complementary H-bond interaction. The simultaneous pres-
ence of both supramolecular interactions (H-bonding and π−π
interactions; Figure 2b) provides a strong synthon connecting
Figure 1. (a) Projection of the crystal packing of CP1 along the
crystallographic b axis, emphasizing the presence of supramolecular
sheets held together by π−π stacking interactions. (b,c) Assembly of
the polymeric 1D chains through hydrogen-bonding interactions.
(d,e) Ladder-like CP and magnification of the metal coordination
surrounding the labeling scheme. Orange single dashed lines indicate
hydrogen-bonding interactions and purple double dashed lines the
π−π stacking interactions. The disorder of the uracil residue has been
omitted for clarity.
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the ladder-like chains and resembles a modest analogue of the
nucleobases’ structural role in DNA.
There are also additional hydrogen-bonding interactions
involving the non-coordinated oxygen atoms of the carboxylate
groups as acceptors and as donors: the N23−H group of the
bridging 5-fluorouracil-acetate ligand (N23−H···O182; D···A:
2.819(8) Å and D−H···A: 156.8°) and the aromatic C−H
positions of the 4,4′-bipy ligand (C38−H···O282; D···A:
3.275(14) Å and D−H···A: 168.8°). Finally, as in CP1, the
irregular shape of the ladder-like chains generates disordered
water molecules that occupy voids within the crystal structure
that comprise 19.0% of the total volume.
The one-pot reaction was carried out at 5 °C with uracil-1-
acetic acid (UAcOH) or 5-FUAcOH, NaOH, 4,4′-bipy, and
Cu(NO3)2·3H2O (Scheme 1), giving rise to the formation of
blue-purple water colloids of CP1n and CP2n. Powder X-ray
diffraction (PXRD) of CP1n and CP2n corroborate that they
retain the same crystal structure of the bulk preparations
(Figures S2 and S4). The morphological characterization,
carried out by FESEM and AFM, confirms that CP1n consists
of well-defined nanoplates 150 ± 75 nm wide and 320 ± 140
nm long with thicknesses between 20 and 40 nm (Figures 3a,b
and S7), while CP2n shows irregular nanoplate structures of
about 284 ± 70 nm wide and 345 ± 90 nm long and heights of
around 40−60 nm (Figures 3c,d and S7).
Stability of CP1n and CP2n in Water and Culture
Media. The evaluation of the lability of the coordination
bonds of CP1n and CP2n in biological media is an interesting
aspect since its knowledge can be turned into a suitable tool for
new drug design. Thus, the response to biological media is a
determining aspect to use these compounds as cell-releasing
molecules. For these reasons, we carried out the chemical
stability studies of the synthesized CP1n and CP2n in water at
different times and pHs and in Dulbecco’s Modifed Eagle's
Medium (DMEM) and Roswell Park Memorial Institute
(RPMI) culture media used in the cell culture studies. The
stability studies were evaluated by SEM, IR, ICP-MS, and
PXRD. The studies carried out in water were done at
physiological pHs (pHs ranges 4−7) and time (from 0 to 1
month). The studies showed that both NCPs are insoluble in
water at 25 °C, displaying similar behavior. The obtained
results confirm that neither are the chemical structures of
CP1n and CP2n altered under these experimental conditions
(Figures S8−S13) nor are their morphologies and dimensions.
On the contrary, the treatment of CP1n and CP2n with
serum-supplemented DMEM and RPMI, at pH 7.2, causes
their immediate hydrolysis and dissolution (see Material and
Methods section).
Figure 2. (a) Crystal packing of CP2 along the crystallographic [110]
direction emphasizing the most relevant supramolecular interactions
taking place. (b,c) Assembly of the polymeric 1D chains through
hydrogen-bonding interactions. (d,e) Ladder-like CP and magnifica-
tion of the metal coordination surrounding with the labeling scheme.
Orange single dashed lines indicate hydrogen-bonding interactions
and purple double dashed lines π−π stacking interactions. The
disorder of the 4,4′-bipy ligand has been omitted for clarity.
Figure 3. (a) FESEM image and (b) AFM topographic image with
the height profile along the green dashed line of the nanoplate from
the CP1n sample and (c) FESEM image and (d) AFM topographic
image with the height profile along the pink dashed line of the
nanoplate from the CP2n sample.
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In order to get insights into these hydrolysis processes, first,
the amount of Cu(II) released in water and biological serum-
supplemented media was quantified by ICP-MS (Table S7).
CP1n and CP2n show similar behavior in water and
different biological media (DMEM and RPMI) (Table S7).
The amount of Cu(II) detected in solution corresponds to 30
(CP1) and 40 (CP2) mg L−1 in water and 20 (CP1) and 31
(CP2) mg L−1 in the biological media, regardless of the
incubation times (no variations between 5 min and 48 h).
These data suggest that the transformation of CP1n and CP2n
in biological media probably leads to new copper species
forming and, eventually, other organic molecules. Furthermore,
these data confirm that both CPs release a similar amount of
Cu(II) in solution; therefore, the difference in the hydrolysis
between both CPs is based on the so-formed species in
solution.
Indeed, CP1n is partially transformed into a light green
coordinat ion compound with the formula [Cu-
(UAcO)2(H2O)4]·H2O
35 after 48 h in DMEM or RPMI
(Scheme 2 and Figure S14). It is important to mention that
this Cu(II)-complex is not soluble in biological media.
However, the mechanism of the [Cu(UAcO)2(H2O)4]·H2O
formation is still unknown, but it should involve the breakage
of the Cu−N coordination bonds corresponding to 4,4′-
bipyridine and its substitution by water molecules from the
media.
On the other hand, in the hydrolysis of CP2n in DMEM and
RPMI, we are not able to isolate the [Cu(FUA)2(H2O)4]·H2O
under similar conditions. The different hydrolysis behaviors
observed for CP1n and CP2n in biological media versus their
similar behaviors in water suggests a significant contribution of
some of the components (amino acids, vitamins, or salts)
present in these media.
Additionally, we have evaluated the behavior of CP1n and
CP2n in the serum-free DMEM and RPMI media and, on the
other hand, with each of the supplements (10% (v/v) fetal
bovine serum (FBS), 2 mM L-glutamine, and 1% penicillin/
streptomycin). The results show that CP1n and CP2n in
biological media hydrolyze in both serum-free media but not in
the supplements alone.
The characterization in the biological media of the possible
species that can be formed is very complicated due to the large
number of components of each media (Scheme 2). However, a
cyclic voltammetry study of CP1n and CP2n in both DMEM
and RPMI also shows the reduction of Cu(II) (Figure 4,
Schemes 2 and S15). Both compounds exhibit very similar
behavior despite the biological medium. The reduction takes
place in two steps; the first one is quasi-reversible, at −1.25 V
versus Ag/AgCl, and the second one is completely irreversible,
at ca. −1.42 V versus Ag/AgCl. When the potential sweep
covers the second component, the first peak’s reoxidation is
lost, and a sharp, small oxidation peak at ca. −1.2 V, which
seems to be due to a species adsorbed on the electrode,
appears. This small peak is somewhat bigger for CP1n. Further
oxidation of reduction products is observed at a much more
positive potential (ca. −0.2 V).
Cell Culture Experiments. All the data previously
mentioned lead us to study the viability of CP1n, CP2n, the
Cu(II)-complex, and the building blocks, UAcOH, 5-
FUAcOH, Cu(AcO)2, and 4,4′-bipyridine in human pancreatic
adenocarcinoma (Panc-1) and human uveal melanoma
(Mel202) cells at different concentrations (Figures 5 and
S16−S20).
A cytotoxicity assay was performed using the dye resazurin.
This compound is usually employed to analyze the percentage
of viable cells since it is an indicator of their active metabolism.
In this sense, Mel202 and Panc-1 cells were treated with CP1n
and [Cu(UAcO)2(H2O)4]·H2O (Cu(II)-complex) at different
concentrations, and the results were analyzed 48 h after
treatment.
On the one hand, CP1n produced a slight reduction in cell
viability at 200 μM to 88 and 83%, respectively (Figure 5a,b,
Scheme 2. (Top) Transformation of CP1n into the
Coordination Complex [Cu(UAcO)2(H2O)4]·H2O (Cu(II)-
Complex) and Cu(I) Species among the Original Building
Blocks in the Culture Media DMEM and RMPI; (Bottom)
Transformation of CP2n in Its Building Blocks and
Different Cu(II) and Cu(I) Species in the Culture Media
DMEM and RMPI
Figure 4. Cyclic voltammetry at 0.1 V/s of CP1n (up) and CP2n
(down) in DMEM.
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orange bars). On the other hand, remarkably, the cell viability
assay in Mel202 and Panc-1 obtained from direct incubation
with [Cu(UAcO)2(H2O)4]·H2O (Cu(II)-complex) at 200
μM (Figure 5a,b, blue bars) shows less toxicity than direct
incubation with CP1n (Figure 5a,b, orange bars) at the same
concentration.
The reduction of copper(II) in biological media, observed in
the cyclic voltammetry study, must be accompanied by
oxidation phenomena. For this reason, to further study the
effect of CP1n in the cell, we evaluated the production of ROS
that influences cell toxicity.36 Thus, ROS production was
studied using the standard probe 2′,7′-dichlorofluorescein
(H2DCFDA) at 48 h after the treatment with different
concentrations of CP1n. The result showed that the Cu(II)-
complex did not produce a significant difference in ROS
generation compared to the control. However, CP1n increased
the ROS level almost 3 times in both cells (Figure 5c,d). It is
known that an excess of ROS can cause damage to cell
organelles, which leads to cell death.37 Therefore, the increase
in the ROS generation could be related to the cytotoxicity of
CP1n.
The fact that CP1n suffers a transformation in the biological
media and the non-significant cytotoxicity showed by the
building blocks (the copper salt, UAcOH, and 4,4′-bipyridine)
(Figures S16 and S17) or by the final Cu(II)-complex
encouraged us to introduce a small but crucial change in
CP1n.
As the structure of CP1n contains free uracil groups along
the chain, the idea is to interchange this uracil by 5-FU, a
crucial antitumor drug, to obtain the isostructural CP2n. This
small and essential change should imply a substantial
improvement in cytotoxicity, given that uracil-1 acetic acid is
innocuous. To anchor the 5-FU moiety correctly to the Cu(II)
metal ion, 5-FUAcOH has been used. The terminal carboxyl
group in 5-FUAcOH gives the molecule charged at
physiological conditions, making it lightly more hydrophilic
and more polar than 5-FU. As a result, 5-FUAcOH cannot
diffuse well through the lipid core of the plasma membrane by
itself. These characteristics reduce 5-FUAcOH’s cytotoxicity
compared to 5-FU (Figure S18). However, recent research has
described that the cytotoxic effect of 5-FUAcOH was enhanced
after being conjugated to biocompatible nanoparticles.38
As both CPs present similar behaviors in the media, the
objective is to verify if the transformation of the new CP2n in
biological media produces an increase in cytotoxicity and ROS
due to the presence of the new building block. In this sense,
Mel202 and Panc-1 cells were treated with CP2n at distinct
concentrations. The results obtained in both cells showed an
outstanding increase in cell cytotoxicity at 200 μM (37 and
34% cell viability, respectively) compared to the Cu(II)-
complex and CP1n (Figure 5a,b). Interestingly, ROS levels
also produce a significant increase of up to 4−5 times.
This remarkable increase in ROS production could be the
main cause of the increased toxicity in both cell lines (Figure
5c,d). These better results show the ability of CP2n to
distribute 5-FUAcOH to the cancer cells as a consequence of
the synergy produced by the transformations observed in
biological media for the CPs, such as the reduction of Cu(II)
observed in the cyclic voltammetry and the introduction of 5-
FuAcOH as a ligand.
To conclude, the conjugation of 5-FUAcOH with Cu(II) in
CP2n is key to increasing the cytotoxic potential of this
antitumor agent, Mel202, and Panc-1 cells treated with a
combination of CP1n + 5-FU and CP1n + 5-FUAcOH. In
Figure 5. Cell viability and ROS production studies on (a,c) Mel202 and (b,d) Panc-1 cells at 48 h after treatment with different concentrations
(1−200 μM) of the Cu(II)-complex (blue), CP1n (orange), and CP2n (gray). ANOVA Tukey’s test (each group vs control). *P < 0.01, **P <
0.001, and ***P < 0.0001 was used for the statistical analysis.
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these cases, the cytotoxicity detected corresponded to that of
the free drugs (Figure S19), which shows that 5-FUAcOH
needs to be anchored to the CP to benefit from its presence.
A comparison of Mel202 and Panc-1 cell viabilities after 48 h
of treatment with CP2n 200 μM and the building blocks at the
equivalent concentrations is shown in Figure S20.
■ EXPERIMENTAL SECTION
Reagents and solvents were acquired from standard chemical suppliers
and employed as received: 4,4′-bipyridyl (4,4′-bipy) 98%, uracil, and
α-chloroacetic acid (Sigma-Aldrich); copper(II) acetate monohy-
drate, copper(II) nitrate trihydrate, hydrochloric acid, and sodium
hydroxide (Scharlab); potassium hydroxide (LabKem); and bromo-
acetic acid and 5-FU (Acros). The ligands UAcOH and 5-FUAcOH
were synthesized as described in the literature.39,40
The methods used for the characterization of the compounds and
the measurements of their magnetic and electrochemical properties as
well as the microscopies used in the morphological study are detailed
in the Supporting Information (Section S1).
(CCDC 2064122−2064123 contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free of charge
from The Cambridge Crystallographic Data Centre via www.ccdc.
cam.ac.uk/data_request/cif).
Bulk Synthesis of [Cu2(UAcO)4(4,4′-bipy)2]n·3H2O (CP1). A
mixture of Cu(NO3)2·3H2O (100 mg, 0.41 mmol), UAcOH (141 mg,
0.82 mmol), and 4,4′-bipy (65 mg, 0.41 mmol) was stirred (10 min)
in water (18 mL) (initial pH = 2.30) at 25 °C. The purple suspension
obtained was subjected to hydrothermal conditions (120 °C for 3
days) and cooled down to 30 °C at a rate of 0.05 °C min−1 (final pH
= 2.57). Purple and turquoise crystals were obtained and separated by
hand. The turquoise crystals were identified as a previously reported
CP with the formula [Cu2(UAcO)2(C2O4) (4,4′-bipy)]·2H2O.10 The
purple crystals were washed (H2O) and dried in air (190 mg, 43%
yield based on Cu). Anal. Calcd for C44H42Cu2N12O19 (CP1): C,
45.17; H, 3.59; N, 14.37. Found: C, 44.84; H, 3.64; N, 14.06 and IR
selected data (ATR) ν (cm−1): 3450 (w), 3100 (w), 3053 (w), 1666
(s), 1630 (s), 1610 (s), 1467 (m), 1391 (s), 1345 (m), 1300 (m),
1239 (m), 1203 (m), 1076 (w), 965 (w), 812 (s), 756 (m), 721 (m),
644 (m). The X-ray diffraction pattern of the purple crystals matches
the diffraction pattern simulated from the structure obtained by
single-crystal X-ray diffraction for CP1 (Figure S1).
Synthesis of Nanostructured [Cu2(UAcO)4(4,4′-bipy)2]n·
3H2O (CP1n). NaOH (33 mg, 0.82 mmol) dissolved in water (3
mL) was added over a water (4 mL) suspension of UAcOH (141 mg,
0.82 mmol). The resulting colorless solution was added while stirring
at 5 °C to a water suspension (4 mL) of 4,4′-bipy (65 mg, 0.41
mmol). The initial white suspension turned into a purple colloid upon
the addition of 3 mL of an aqueous solution of Cu(CH3COO)2·H2O
(82 mg, 0.41 mmol). The purple colloid was stirred at 1200 rpm for 5
min, centrifuged (3 min) at 5000 rpm, and washed with 56 mL of
Milli-Q water. The solid was dried in air (180 mg, 38% yield based on
Cu). Anal. Calcd for C44H42Cu2N12O19 (CP1n): C, 45.17; H, 3.59;
N, 14.37. Found: C, 44.81; H, 3.67; N, 14.14 and IR selected data
(ATR) ν (cm−1): 3490 (w), 3104 (w), 3059 (w), 1676 (s), 1626 (s),
1606 (s), 1433 (m), 1390 (s), 1348 (m), 1297 (m), 1233 (m), 1203
(m), 1075 (w), 967 (w), 813 (s), 762 (m), 727 (m), 642 (m). PXRD
data confirm that the obtained solid corresponds to CP1 (Figure S2).
Bulk Synthesis of [Cu2(5-FUAcO)4(4,4′-bipy)2]n·4H2O (CP2).
Cu(NO3)2·3H2O (100 mg, 0.41 mmol), 5-FUAcOH (150 mg, 0.82
mmol), and 4,4′-bipy (65 mg, 0.41 mmol) were stirred together in
water (18 mL, initial pH = 2.68) at 25 °C for 10 min. The purple
suspension obtained was subjected to hydrothermal conditions (120
°C for 2 days) and cooled down to 30 °C at a rate of 0.05 °C min−1
(final pH = 2.54). Low amounts of unstable yellow crystals and deep
purple crystals were obtained. The purple crystals were separated by
hand, washed with water, and dried in air (40 mg, 7.3% yield based on
Cu). Anal. Calcd for C44H48Cu2N12O24F4 (CP2): C, 39.67; H, 3.61;
N, 12.62. Found: C, 40.52; H, 3.66; N, 11.93 and IR selected data
(ATR) ν (cm−1): 3498 (w), 3171 (w), 3063 (w), 2823 (w), 1700 (s),
1661 (s), 1635 (s), 1602 (s), 1495 (w), 1475 (w), 1413 (m), 1398
(s), 1381 (s), 1368 (s), 1342 (m), 1320 (m), 1300 (s), 1241 (s),
1190 (w), 1144 (m), 1073 (m), 985 (m), 898 (m), 813 (s), 798 (s),
762 (m), 698 (m), 642 (m). X-ray diffraction confirms that purple
crystals belong to CP2 (Figure S3).
Synthesis of Nanostructured [Cu2(5-FUAcO)4(4,4′-bipy)2]n·
4H2O (CP2n). A mixture of 5-FUAcOH (150 mg, 0.82 mmol) and
NaOH (32 mg, 0.82 mmol) in water (total volume 7 mL) was added
under stirring at 5 °C to a water suspension (4 mL) of 4,4′-bipy (65
mg, 0.41 mmol). After the addition of 3 mL of an aqueous solution of
Cu(NO3)2·3H2O (100 mg, 0.41 mmol), the resulting white
suspension turned into a purple colloid, which was stirred at 1200
rpm (5 min), centrifuged at 5000 rpm (3 min), and washed with
Milli-Q water (56 mL). The solid was dried in air (78 mg, % yield
based on Cu). Anal. Calcd for C44H48Cu2N12O24F4 (CP2n): C, 39.67;
H, 3.61; N, 12.62. Found: C, 39.67; H, 3.58; N, 12.42 and IR selected
data (ATR) ν (cm−1): 3492 (w), 3104 (w), 3059 (w), 1675 (s), 1626
(s), 1603 (s), 1431 (m), 1389 (s), 1348 (m), 1297 (m), 1233 (m),
1201 (m), 1075 (w), 967 (w), 813 (s), 764 (m), 727 (m), 641 (m).
PXRD data confirm that the solid corresponds to CP2 (Figure S4).
Stability of CP1n and CP2n in Water. The initial pH value of
ca. 5.7 for CP1n and CP2n colloids was readjusted upon addition of
(i) an aqueous solution of NaOH 0.01 M until reaching pH = 7 and
(ii) an aqueous solution of HCl 0.01 M until reaching pH = 4. The
obtained suspensions were analyzed by PXRD, IR, and SEM, showing
that both coordination compounds are chemically and morpholog-
ically stable without significant changes (Figures S8, S9, S11, and
S12).
Freshly prepared colloidal suspensions of both samples (CP1n and
CP2n) (t = 0) were stored in closed vials at 25 °C for 1 month (initial
and final pH = 5.7). Their stability in solution within time was also
evaluated with SEM and PXRD. The studies show identical PXRDs
and do not show evident morphological changes (Figures S10 and
S13).
The behavior of CP1n and CP2n in water was evaluated by ICP−
MS, measuring the amount of copper(II) ions at different reaction
times (5 min, 15 min, 1 h, 24 h, and 48 h). For this study, five samples
were prepared by addition of 100 μL of NCPs to 900 μL of Milli-Q
water and centrifuged at different time points using standard dialysis
centrifugal filters (Amicon 10 kDa) to remove the solid (Table S7).
Cell Culture. Panc-1 cells were obtained from American Type
Culture Collection (ATCC), and human uveal melanoma (Mel202)
cells were provided by the University of California, San Francisco, Dr.
Susana Ortiz-Urda laboratory.
Panc-1 cells were grown in DMEM, while Mel202 cells were
cultured in RPMI 1640 medium. Both cell culture mediums were
supplemented with 10% (v/v) FBS, 2 mM L-glutamine, and 1%
penicillin/streptomycin. The experiments were done on subconfluent
cells incubated under standard conditions (37 °C, 5% CO2).
Stability of CP1n and CP2n in Culture Media. Since the cells
are grown in the culture media DMEM and RPMI supplemented with
10% (v/v) FBS, 2 mM L-glutamine, and 1% penicillin/streptomycin
(serum-supplemented medium), studies were carried out to analyze
the stability of CP1n and CP2n in the cell culture media.
100 μL of CP1n or CP2n was incubated with 900 μL of the serum-
supplemented medium (DMEM or RPMI). A blank sample using just
water instead of the serum-supplemented media at room temperature
was also studied. It becomes clear that only after a few seconds in the
medium, CP1n and CP2n underwent a chemical transformation,
leading to the complete dissolution of the initial materials. The
mixtures were centrifuged from 1 min to 1 h without the appearance
of any solid. 48 h later, a light green solid appeared in the CP1n
media solutions, which was characterized by PXRD as the complex
[Cu(UAcO)2(H2O)4]·2H2O (Cu(II)-complex) (Figure S14).
The behavior of CP1n and CP2n in the supplemented media was
evaluated by ICP-MS, measuring the amount of copper(II) ions at
different reaction times (5 min, 15 min, 1 h, 24 h, and 48 h) under the
same experimental conditions mentioned above. The samples were
centrifuged using standard dialysis centrifugal filters (Amicon 10 kDa)
to remove the solid (Table S7).
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Cytotoxicity Assay. The uveal melanoma (Mel 202) cell line and
pancreatic cancer cells (Panc-1) were seeded in 24-well plates and
incubated at standard conditions. Then, the cells were incubated with
the corresponding compound for 24 h at different concentrations:
CP1n, CP2n, 4,4′-bipy, and UAcOH (1−200 μM); Cu(AcO)2
(2.04−408 μM); and 5-FU and 5-FUAcOH (3.9−788 μM). After
incubation, the culture medium was taken away, and the cells were
washed with PBS 1×. 48 h after treatment, using resazurin assay
following the manufacturer’s protocol, toxicity was measured.41 The
cell culture medium was replaced by a fresh one containing 1%
resazurin solution (1 mg mL−1 in PBS). In addition, cells were
incubated at 37 °C, 5% CO2 for 3 h more. A microplate reader (λexc =
550/20 nm, λem = 590/20 nm) was used to measure the fluorescence.
Data corresponded to mean values ± standard deviation. For
statistical calculations, one-way ANOVA and Tukey’s Test in R
Commander software was used.42 P values <0.05 (*), <0.01 (**), and
<0.001 (***) were considered as statistically significant (Figures
S15−S17).
ROS Generation Assay. Cells were plated in 96-well plates (15 ×
103 cells well−1) and incubated at standard conditions. After that, the
cells were treated (24 h) with different concentrations of CP1n and
CP2n, washed twice with fresh medium, and further incubated for 24
h. Then, cells were incubated with 5 μM H2DCFDA for 30 min at 37
°C, 5% CO2. Finally, cells were washed with 1× PBS (pH 7.4). Again,
a microplate reader (λexc = 485/20 nm, λem = 535/20 nm) was used to
measure the fluorescence. Values were normalized with the results of
the cell viability assay. Data represent the mean values ± standard
deviation. For statistical calculations, one-way ANOVA and Tukey’s
Test in R Commander software was used.42 P values <0.05 (*), <0.01
(**), and <0.001 (***) were considered as statistically significant
(Figure 5).
■ CONCLUSIONS
Previous studies have shown great interest in synthesizing
Cu(II) NCPs with modified nucleobases and molecular
recognition capabilities because of their potential use as
nanocarriers for drugs or molecules of biological interest.15
However, this work shows a different perspective of the
potential use of nanostructured CPs generating active species
in a medium upon hydrolysis. Thus, we have demonstrated
that a suitable combination of building blocks forming the CP
networks allows their use as precursor nanocarriers of active
drugs.
We have prepared water colloids of two CPs based on
Cu(II) decorated with 5-fluorouracil-1-acetate and uracil-1-
acetate as terminal ligands and studied their hydrolysis in
biological media. We confirmed that these reactions provoke
molecular reorganizations leading to the formation of soluble
copper species and organic molecules.
Interestingly, the cytotoxic cell studies show that while
CP1n shows a decrease in the cell viability of ca. 17%, its
molecular precursors and the Cu(II) complex that is formed in
the media do not show toxicity under similar conditions.
Furthermore, CP1n produces an enhancement of ROS levels
in cells three times higher than ROS levels in cells. This
observation correlates well with the reduction phenomena
observed in CV studies and suggests that the cytotoxicity
observed for CP1n produces oxidative stress in a similar way to
that described for related Zn-MOFs.30
These observations suggest the design of an isostructural CP
to improve the cytotoxic activity, in which the difference is the
substitution of uracil-1-acetate by 5-fluorouracil-1-acetate as
the terminal ligand since 5-fluorouracil-1-acetate is a derivative
of the essential anticancer agent 5-FU.43 The new CP2n
presents a similar behavior in the biological media to that of
CP1n. However, it shows both a considerable increase in
cellular toxicity (up to 66%) and a significant increase in ROS
species’ formation (five times the level of ROS in cells).
Therefore, because the copper species produced by the
hydrolysis of CP1n and CP2n are similar, the difference in
toxicity is ascribed to the organic species generated in the
medium and the reduction phenomena. Therefore, we believe
that the presence of species containing the 5-FU moiety in the
hydrolysis of CP2n causes a significant increase in its
cytotoxicity.
In summary, this work suggests a novel approach for
designing therapeutic drugs based on the rational design of
their structures in which their hydrolysis in biological media
generates active drugs. However, it also takes advantage of the
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